AF 102Alternative Names: AF102
Latest Information Update: 08 Jan 2016
At a glance
- Originator PUMC Pharmaceutical Company
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preregistration Fissure in ano
Most Recent Events
- 15 Mar 2016 Biomarkers information updated
- 06 Jan 2016 Preregistration for Fissure in ano in China (unspecified route) before January 2016